Healthcare -
Biotechnology - NASDAQ - US
$ 9.705
0.674 %
$ 2.9 B
Market Cap
-28.54
P/E
FOLD - CAPITAL EXPENDITURES
Capital Expenditures FOLD - Amicus Therapeutics, Inc.
-7.44 M
LAST VALUE
-38.40%
2 YEAR CAGR
-3.36%
5 YEAR CAGR
-26.75%
10 YEAR CAGR